Daewoong pharmaceutical Co.,Ltd reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was KRW 340,899.76 million compared to KRW 331,893.49 million a year ago. Net income was KRW 15,578.69 million compared to KRW 20,502.25 million a year ago. Basic earnings per share from continuing operations was KRW 1,354 compared to KRW 1,852 a year ago. Basic earnings per share was KRW 1,354 compared to KRW 1,852 a year ago.
For the nine months, sales was KRW 6,306.87 million compared to KRW 1,132.31 million a year ago. Net income was KRW 55,730.32 million compared to KRW 51,588.79 million a year ago. Basic earnings per share from continuing operations was KRW 4,890 compared to KRW 4,661 a year ago. Basic earnings per share was KRW 4,890 compared to KRW 4,661 a year ago.